Ahren is a deep tech and deep science investment firm established to back transformational enterprises. The firm manages significant capital and maintains a portfolio spanning several prominent technology and science companies.
The oversubscribed financing was led by Ahren Innovation Capital and will support preclinical validation and platform development.
"Partnering with the team at o2h discovery is a fantastic milestone for OutSee as we look ahead to commencing our first drug discovery programme and showcasing the potential of our Nomaly platform to revolutionise target discovery. The agreement is testament to the strength of our technology and, in combination with the closure of our oversubscribed seed funding round, kicks off a very exciting year. Thank you to our investors and supporters for their continued support, and the hard work and dedication of our team."
Flying Fish Ventures led the seed round to support product development and research capabilities at Hiverge.
"Our quantum research demands highly specialised algorithmic approaches. We’re excited to be collaborating with Hiverge and using its platform to discover novel quantum algorithms. We see strong potential for this partnership to accelerate the scientific breakthroughs we’re pursuing."
The financing round was led by Ahren Innovation Capital and will support the expansion of the company's in-house target discovery programme.
"OutSee’s Nomaly technology is a truly next-generation genomic analysis tool with potential to transform drug discovery using powerful data-driven insights. It allows us to interrogate smaller datasets, and even data that has already been analysed, to uncover unique target insights that until now would have remained undetected."
The seed round was co-led by Creator Fund and LocalGlobe to help the biotech startup move its egg-quality treatment toward the clinic.
"Ovo Labs’ mission is to make the dream of parenthood a reality for millions of couples who struggle to conceive. By helping to increase the number of viable eggs, we aim to extend the reproductive window, empowering more couples to have children at a time that feels right to them. Ovo Labs’ technology also offers a potential solution for declining birth rates, which is a trend observed in many countries worldwide."
